HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors

The frequent development of drug resistance to targeted therapies in cancer patients has stimulated interest in strategies counteracting resistance. Combining immunotherapies with targeted therapies is one such strategy. In this context, we asked whether human NK cells can target melanoma cells that...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Immunol
Main Authors: Sottile, Rosa, Pangigadde, Pradeepa N., Tan, Thomas, Anichini, Andrea, Sabbatino, Francesco, Trecroci, Francesca, Favoino, Elvira, Orgiano, Laura, Roberts, James, Ferrone, Soldano, Kärre, Klas, Colucci, Francesco, Carbone, Ennio
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Immunomodulation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4832274/
https://ncbi.nlm.nih.gov/pubmed/26564811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201445289
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados